Kytril and Maxzide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kytril (granisetron hydrochloride) and Maxzide (hydrochlorothiazide; triamterene). Common drug interactions include heart rate increased among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Kytril and Maxzide. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Kytril?

Kytril has active ingredients of granisetron hydrochloride. eHealthMe is studying from 10,766 Kytril users. Check the latest studies of Kytril.

What is Maxzide?

Maxzide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. eHealthMe is studying from 9,152 Maxzide users. Check the latest studies of Maxzide.



On Jul, 11, 2026

26 people who take Kytril and Maxzide together, and have interactions are studied.

Kytril and Maxzide drug interactions.

What are the common drug interactions of Kytril and Maxzide, by gender? *:

female:

  1. Heart rate increased
  2. Hypersensitivity
  3. Incision site complication
  4. Injury
  5. Insomnia (sleeplessness)
  6. Intestinal obstruction
  7. Laryngitis (inflammation of the larynx)
  8. Lethargy (tiredness)
  9. Limb discomfort (discomfort in leg)
  10. Local swelling (swelling at the site of some application of substance or injury)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Alopecia (absence of hair from areas of the body)
  3. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Dyspnoea (difficult or laboured respiration)
  6. Epistaxis (bleed from the nose)
  7. Haematuria (presence of blood in urine)
  8. Herpes zoster
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)

What are the common drug interactions of Kytril and Maxzide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cough
  2. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dyspnoea (difficult or laboured respiration)
  5. Nausea (feeling of having an urge to vomit)
  6. Pericardial effusion (fluid around the heart)
  7. Pleural effusion (water on the lungs)
  8. Rash erythematous (redness of the skin)
  9. Tenderness (pain or discomfort when an affected area is touched)

50-59:

  1. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  2. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  3. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Dehydration (dryness resulting from the removal of water)
  6. Dizziness
  7. Dizziness postural
  8. Dyspnoea (difficult or laboured respiration)
  9. Fatigue (feeling of tiredness)
  10. Heart rate increased

60+:

  1. Breast cancer metastatic
  2. Hepatic failure (liver failure)
  3. Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
  4. Diarrhoea
  5. Epistaxis (bleed from the nose)
  6. General physical health deterioration (weak health status)
  7. Haematuria (presence of blood in urine)
  8. Herpes zoster
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Impaired healing

What are the existing conditions these people have? *

  1. Pain: 4 people, 15.38%
  2. Ovarian Cancer (cancer of ovary): 4 people, 15.38%
  3. High Blood Cholesterol: 3 people, 11.54%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
  5. Asthma: 3 people, 11.54%
  6. Breast Cancer Metastatic: 3 people, 11.54%
  7. Constipation: 3 people, 11.54%
  8. Depression: 3 people, 11.54%
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 11.54%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Kytril and Maxzide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kytril and Maxzide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kytril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Maxzide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kytril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxzide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on granisetron hydrochloride and hydrochlorothiazide; triamterene (the active ingredients of Kytril and Maxzide, respectively), and Kytril and Maxzide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: